Oregon 2025R1 Session Status: In Committee Bipartisan · 3 D · 1 R cosponsors

HB 2536 — Prohibits health benefit plans from requiring step therapy prior to covering a prescription drug for the treatment of metastatic cancer and associated conditions.

Last action — In House Committee

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced January 17, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 38% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 4 sponsors

    2 primary, 2 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (3 D · 1 R) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Digest: The Act bans health benefit plans from using step therapy for certain cancer drugs and treatments. (Flesch Readability Score: 63.6). Prohibits health benefit plans from requiring step therapy prior to covering a prescription drug for the treatment of metastatic cancer and associated conditions.

Bill Text

We don't have the full text on file for this bill yet.

Read HB 2536 on the official Oregon source →

Action History

  1. In House Committee

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

2 sponsors · 2 co-sponsors · 86 not signed on

Sponsors (2)

Co-sponsors (2)

Not signed on (86)

86 members have not signed on to this bill.

Show all 86 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 2536 do?
Digest: The Act bans health benefit plans from using step therapy for certain cancer drugs and treatments. (Flesch Readability Score: 63.6). Prohibits health benefit plans from requiring step therapy prior to covering a prescription drug for the treatment of metastatic cancer and associated conditions.
Who sponsors HB 2536?
HB 2536 is sponsored by Dacia Grayber (Democrat), Kate Lieber (Democrat), Lew Frederick (Democrat), and Cyrus Javadi (Republican).
What is the current status of HB 2536?
This bill is in committee in the House. Introduced January 17, 2025. It must pass committee before a floor vote.
Where can I track HB 2536?
Track HB 2536 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2536

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 2536

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →